Founded in 2013, heliosX is a digital health group operating a vertically integrated network of clinicians, pharmacies, and manufacturers across nine countries. The company serves over 1.7 million patients worldwide and generated £781 million in revenue in 2025. Its structure combines telemedicine platforms, pharmacy operations, and pharmaceutical manufacturing under unified ownership, enabling it to prescribe and deliver medicines globally.
The group operates multiple consumer-facing brands including MedExpress, ZipHealth, RocketRX, and others, each serving different segments of digital healthcare delivery. Clinical operations are led by in-house medical teams, researchers, and pharmacists, distinguishing the company from platforms that rely solely on third-party practitioners. This model allows the company to maintain direct control over clinical quality and pharmaceutical supply chains.
heliosX is bootstrapped and profitable, having funded its expansion without external investment. The company continues to grow internationally while maintaining focus on accessibility and trustworthiness in healthcare delivery.
